Integra LifeSciences Holdings Stock Forecast for 2023 - 2025 - 2030

Updated on 03/28/2024

Stock Rating
16
Price Target
$43.50
Consensus
Neutral
Upside
20.10%
Analysts
4
Stock Rating
16
Upside
20.10%
Analysts
4
Price Target
$43.50

Integra LifeSciences Holdings Stock Forecast and Price Target

If Integra LifeSciences Holdings's stock price reached the average yearlong target of $43.50 given by four well-known analysts in recent months, there would be a potential upside of approximately 20.1% from its last closing price in March, 2024. This potential increase is based on a high estimate of $57.00 and a low estimate of $37.00. If you are looking to invest in the stock, it's important to research and compare different companies.

$43.50

20.10% Upside

Hold
Hold

Integra LifeSciences Holdings Fair Value Forecast for 2023 - 2025 - 2030

In the last four years, Integra LifeSciences Holdings's Price has decreased from $46.77 to $0.00 – a 100.00% drop. In the next year, analysts believe that Fair Value will reach $65.86 – an increase of 100.00%. For the next seven years, experts predict that Integra LifeSciences Holdings's Fair Value will grow at a rate of 100.00%.

2024 Fair Value Forecast
$65.86
2025 Fair Value Forecast
$73.31
2026 Fair Value Forecast
$81.32
2027 Fair Value Forecast
$97.17
2028 Fair Value Forecast
$98.31
2029 Fair Value Forecast
$89.35
2030 Fair Value Forecast
$87.13
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
ABBV Stock Forecast AbbVie Outperform 9
$179.63 Buy/Sell $178.42 0.21%
PFE Stock Forecast Pfizer Outperform 2
$28.37 Buy/Sell $32.87 10.82%
SIE Stock Forecast Siemens Outperform 10
180.62€ Buy/Sell 178.14€ 7.96%
SYK Stock Forecast Stryker Corp Outperform 10
$355.59 Buy/Sell $353.16 1.38%
ISRG Stock Forecast Intuitive Surgical Outperform 13
$378.90 Buy/Sell $408.45 11.38%

Integra LifeSciences Holdings Revenue Forecast for 2023 - 2025 - 2030

Integra LifeSciences Holdings's Revenue has grown In the last three years, rising from $1.37B to $1.54B – a growth of 12.37%. In the next year, analysts believe that Revenue will reach $1.62B – an increase of 4.87%. For the next eight years, experts predict that Integra LifeSciences Holdings's Revenue will grow at a rate of 22.67%.

2024 Rev Forecast
$1.62B
2025 Rev Forecast
$1.70B
2026 Rev Forecast
$1.79B
2026 Rev Forecast
$1.79B
2027 Rev Forecast
$1.95B
2028 Rev Forecast
$2.02B
2029 Rev Forecast
$1.94B
2030 Rev Forecast
$1.89B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
MDT Stock Forecast Medtronic Outperform 11
$85.50 Buy/Sell $92.47 11.11%
BSX Stock Forecast Boston Scientific Outperform 11
$66.12 Buy/Sell $70.14 8.89%
EW Stock Forecast Edwards Lifesciences Corp Outperform 11
$90.83 Buy/Sell $91.18 1.84%

Integra LifeSciences Holdings Dividend per Share Forecast for 2023 - 2025 - 2030

2024 DPS Forecast
$0.00
2025 DPS Forecast
$0.00
2026 DPS Forecast
$0.00
2027 DPS Forecast
$0.00
2028 DPS Forecast
$0.00
2029 DPS Forecast
$0.00
2030 DPS Forecast
$0.00
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
MMM Stock Forecast 3M Hold 10
$94.05 Buy/Sell $109.39 15.90%
COLO B Stock Forecast Coloplast A/S Hold 18
kr965.20 Buy/Sell kr812.28 -6.76%
RMD Stock Forecast ResMed Inc Outperform 17
$189.75 Buy/Sell $201.32 8.04%

Integra LifeSciences Holdings Free Cash Flow Forecast for 2023 - 2025 - 2030

2024 FCF Forecast
$0.25B
2025 FCF Forecast
$0.29B
2026 FCF Forecast
$0.28B
2027 FCF Forecast
$0.27B
2028 FCF Forecast
$0.27B
2029 FCF Forecast
$0.27B
2030 FCF Forecast
$0.28B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
ZBH Stock Forecast Zimmer Biomet Holdings Hold 15
$128.04 Buy/Sell $132.52 5.44%
WST Stock Forecast West Pharmaceutical Services Outperform 18
$357.52 Buy/Sell $380.80 6.29%
STE Stock Forecast STERIS Outperform 13
$233.84 Buy/Sell $238.33 4.77%

Integra LifeSciences Holdings EBITDA Forecast for 2023 - 2025 - 2030

In the last three years, Integra LifeSciences Holdings has seen a decline in its EBITDA, from $335.84M to $123.90M – a 63.11% decrease. In the next year, analysts predict that EBITDA will jump to $407.34M – up 228.77% from the current level. Looking ahead to eight years, experts forecast that EBITDA will grow by 320.74%.

2024 EBITDA Forecast
$0.41B
2025 EBITDA Forecast
$0.45B
2026 EBITDA Forecast
$0.50B
2026 EBITDA Forecast
$0.50B
2027 EBITDA Forecast
$0.51B
2028 EBITDA Forecast
$0.55B
2029 EBITDA Forecast
$0.53B
2030 EBITDA Forecast
$0.52B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
COO Stock Forecast The Cooper Companies Outperform 13
$101.44 Buy/Sell $391.40 4.99%
PHIA Stock Forecast Koninklijke Philips N.V. Hold 18
19.63€ Buy/Sell 19.42€ -0.66%
HOLX Stock Forecast Hologic Outperform 8
$76.33 Buy/Sell $81.06 7.56%

Integra LifeSciences Holdings EBIT Forecast for 2023 - 2025 - 2030

In the last three years, Integra LifeSciences Holdings's EBIT has decreased by 49.26%, from $219.81M to $111.53M. Analysts predict that Integra LifeSciences Holdings's EBIT will increase in the upcoming year, reaching $361.56M. This would represent an increase of 224.18%. Over the next eight years, experts predict that Integra LifeSciences Holdings's EBIT will grow at a rate of 331.72%.

2024 EBIT Forecast
$0.36B
2025 EBIT Forecast
$0.40B
2026 EBIT Forecast
$0.45B
2026 EBIT Forecast
$0.45B
2027 EBIT Forecast
$0.51B
2028 EBIT Forecast
$0.53B
2029 EBIT Forecast
$0.50B
2030 EBIT Forecast
$0.48B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
ABMD Stock Forecast Abiomed - 16
$377.79 Buy/Sell $380.00 -88.33%
SN. Stock Forecast Smith & Nephew Outperform 18
£10.91 Buy/Sell £16.09 53.35%
TFX Stock Forecast Teleflex Inc Hold 13
$227.11 Buy/Sell $263.46 16.68%

Integra LifeSciences Holdings EPS Price Prediction Forecast for 2023 - 2025 - 2030

In the last four years, Integra LifeSciences Holdings's EPS has decreased from $2.45 to $0.00 – a 100.00% drop. In the next year, analysts believe that EPS will reach $3.45 – an increase of 100.00%. For the next seven years, experts predict that Integra LifeSciences Holdings's EPS will grow at a rate of 100.00%.

2024 EPS Forecast
$3.45
2025 EPS Forecast
$3.84
2026 EPS Forecast
$4.26
2027 EPS Forecast
$5.09
2028 EPS Forecast
$5.15
2029 EPS Forecast
$4.68
2030 EPS Forecast
$4.56
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
GMED Stock Forecast Globus Medical Outperform 16
$55.10 Buy/Sell $64.58 12.52%
XRAY Stock Forecast DENTSPLY SIRONA Outperform 17
$33.87 Buy/Sell $36.00 10.72%
CTEC Stock Forecast ConvaTec Group PLC Outperform 16
£2.81 Buy/Sell £3.43 33.81%